Suchergebnisse - "Alotaibi, Ahmad S"

PubPharm (6)

1

An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis

enthalten in: Blood | 2022

von Zoref-Lorenz, A. | Murakami, J. | Hofstetter, L. | +17

CommentIn: Blood. 2022 Feb 17;139(7):961-963. - PMID 35175327

2

T-cell-based immunotherapy of acute myeloid leukemia : current concepts and future developments

enthalten in: Leukemia | 2021

von Daver, N. | Alotaibi, A. | Bücklein, V. | +1

3

Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 inhibitors

enthalten in: Blood cancer discovery | 2021

von Alotaibi, A. | Yilmaz, M. | Kanagal-Shamanna, R. | +24

CommentIn: Blood Cancer Discov. 2020 Dec 06;2(2):113-115. - PMID 34661152

4

Clinical characteristics and outcomes in patients with acute myeloid leukemia with concurrent FLT3-ITD and IDH mutations

enthalten in: Cancer | 2021

von Shoukier, M. | Kadia, T. | Konopleva, M. | +21

5

Acute promyelocytic leukemia (APL) with an IRF2BP2-RARA fusion transcript : an aggressive APL variant

enthalten in: Leukemia & lymphoma | 2020

von Alotaibi, A. | Abdulrazzaq, M. | Patel, K. | +10

6

Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML

enthalten in: Journal of hematology & oncology | 2020

von Yilmaz, M. | Alfayez, M. | DiNardo, C. | +22

ErratumIn: J Hematol Oncol. 2021 Feb 23;14(1):34. - PMID 33618754

1
[1]